Argenx Se (DE:1AEA)

FRANKFURT:1AEA

1AEA

Argenx Se

RESEARCH TOOLSreports

Want to see DE:1AEA full AI Analyst Report?

Argenx Se (1AEA) Stock Forecast & Price Target

13 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

1AEA Analyst Ratings

Strong Buy

17 Buy

2 Hold

0 Sell

Based on 19 analysts giving stock ratings to

Argenx

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

1AEA Stock 12 Month Forecast

Average Price Target

€872.31

▲(25.51% Upside)

Based on 19 Wall Street analysts offering 12 month price targets for Argenx Se in the last 3 months. The average price target is €872.31 with a high forecast of €1,056.41 and a low forecast of €720.09. The average price target represents a 25.51% change from the last price of €695.00.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"461":"€461","610":"€610","759":"€759","908":"€908","1057":"€1,057"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1056.4090188,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€1.06K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":872.312592276,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€872.31</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":720.08634,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€720.09</span>\n  </div></div>","useHTML":true}}],"tickPositions":[461,610,759,908,1057],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2025","6":"Oct<br/>2025","9":"Jan<br/>2026","12":"Apr<br/>2026","25":"Apr<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,625,658.1853091384615,691.3706182769231,724.5559274153846,757.7412365538462,790.9265456923077,824.1118548307693,857.2971639692307,890.4824731076924,923.6677822461538,956.8530913846155,990.0384005230769,1023.2237096615385,{"y":1056.4090188,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,625,644.0240455596924,663.0480911193846,682.072136679077,701.0961822387692,720.1202277984615,739.1442733581539,758.1683189178461,777.1923644775385,796.2164100372308,815.2404555969231,834.2645011566154,853.2885467163078,{"y":872.312592276,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,625,632.3143338461539,639.6286676923077,646.9430015384615,654.2573353846153,661.5716692307692,668.8860030769231,676.2003369230769,683.5146707692307,690.8290046153845,698.1433384615384,705.4576723076923,712.7720061538461,{"y":720.08634,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":540,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 42,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":570,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 51,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":496,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 56,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":462,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 55,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":575,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 58,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":600,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 54,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":615,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 67,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":705,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 48,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":770,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 48,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":700,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 66,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":690,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 76,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":640,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 87,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":625,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 45,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€1,056

Average Price Target€872.31

Lowest Price Target€720.09

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

David Nierengarten

Wedbush

€848.15

Buy

22.04%

Upside

Reiterated

04/16/26

Analysts Offer Insights on Healthcare Companies: Argenx Se (NASDAQ: ARGX) and Avalo Therapeutics (NASDAQ: AVTX)

Yaron Werber

TD Cowen

€971.98

Buy

39.85%

Upside

Reiterated

04/14/26

Analysts Offer Insights on Healthcare Companies: Cytokinetics (NASDAQ: CYTK), Argenx Se (NASDAQ: ARGX) and Sight Sciences (NASDAQ: SGHT)

Tazeen Ahmad

Bank of America Securities

―

Buy

―

Reiterated

04/14/26

Analysts Are Bullish on Top Healthcare Stocks: Opus Genetics (IRD), Argenx Se (ARGX)

Luca Issi

RBC Capital

€754.85

Buy

8.61%

Upside

Reiterated

04/07/26

RBC Capital Reaffirms Their Buy Rating on Argenx Se (ARGX)

Leland Gershell

Oppenheimer

€899.04→€860.02

Buy

23.74%

Upside

Assigned

04/02/26

Analysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (NYSE: TEVA), Nuvation Bio (NYSE: NUVB) and Argenx Se (NASDAQ: ARGX)

Derek Archila

Wells Fargo

€1,272.22→€1,057.64

Buy

52.18%

Upside

Reiterated

04/01/26

Argenx Se (ARGX) Gets a Buy from Wells Fargo

Xian Deng

UBS

€720.93

Hold

3.73%

Upside

Reiterated

04/01/26

UBS Keeps Their Hold Rating on Argenx Se (ARGX)

Douglas Tsao

H.C. Wainwright

€797.26

Buy

14.71%

Upside

Reiterated

03/02/26

Analysts Are Bullish on Top Healthcare Stocks: Argenx Se (ARGX), Indivior (INDV)

Allison Bratzel

Piper Sandler

€911.76

Buy

31.19%

Upside

Reiterated

02/27/26

Argenx Se (ARGX) Gets a Buy from Piper Sandler

Jason Butler

Citizens JMP

€784.54→€800.65

Buy

15.20%

Upside

Reiterated

02/27/26

Argenx price target raised to $944 from $925 at CitizensArgenx price target raised to $944 from $925 at Citizens

Danielle Brill

Truist Financial

―

Buy

―

Reiterated

02/27/26

Analysts Are Bullish on Top Healthcare Stocks: Argenx Se (ARGX), Neurogene (NGNE)

Sean Laaman

Morgan Stanley

€983.85→€1,043.22

Buy

50.10%

Upside

Reiterated

02/27/26

Analysts Offer Insights on Healthcare Companies: Entrada Therapeutics Inc (NASDAQ: TRDA), Kymera Therapeutics (NASDAQ: KYMR) and Argenx Se (NASDAQ: ARGX)

Colleen M. Kusy

Robert W. Baird

€727.71→€735.35

Hold

5.81%

Upside

Reiterated

02/27/26

Argenx price target raised to $867 from $858 at BairdArgenx price target raised to $867 from $858 at Baird

Unknown Analyst

Jefferies

Not Ranked

Jefferies

€854.93

Buy

23.01%

Upside

Reiterated

02/27/26

Jefferies Remains a Buy on Argenx Se (ARGX)

Yatin Suneja

Guggenheim

€983.85→€949.93

Buy

36.68%

Upside

Reiterated

02/26/26

Argenx price target lowered to $1,120 from $1,160 at GuggenheimArgenx price target lowered to $1,120 from $1,160 at Guggenheim

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

David Nierengarten

Wedbush

€848.15

Buy

22.04%

Upside

Reiterated

04/16/26

Analysts Offer Insights on Healthcare Companies: Argenx Se (NASDAQ: ARGX) and Avalo Therapeutics (NASDAQ: AVTX)

Yaron Werber

TD Cowen

€971.98

Buy

39.85%

Upside

Reiterated

04/14/26

Analysts Offer Insights on Healthcare Companies: Cytokinetics (NASDAQ: CYTK), Argenx Se (NASDAQ: ARGX) and Sight Sciences (NASDAQ: SGHT)

Tazeen Ahmad

Bank of America Securities

―

Buy

―

Reiterated

04/14/26

Analysts Are Bullish on Top Healthcare Stocks: Opus Genetics (IRD), Argenx Se (ARGX)

Luca Issi

RBC Capital

€754.85

Buy

8.61%

Upside

Reiterated

04/07/26

RBC Capital Reaffirms Their Buy Rating on Argenx Se (ARGX)

Leland Gershell

Oppenheimer

€899.04→€860.02

Buy

23.74%

Upside

Assigned

04/02/26

Analysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (NYSE: TEVA), Nuvation Bio (NYSE: NUVB) and Argenx Se (NASDAQ: ARGX)

Derek Archila

Wells Fargo

€1,272.22→€1,057.64

Buy

52.18%

Upside

Reiterated

04/01/26

Argenx Se (ARGX) Gets a Buy from Wells Fargo

Xian Deng

UBS

€720.93

Hold

3.73%

Upside

Reiterated

04/01/26

UBS Keeps Their Hold Rating on Argenx Se (ARGX)

Douglas Tsao

H.C. Wainwright

€797.26

Buy

14.71%

Upside

Reiterated

03/02/26

Analysts Are Bullish on Top Healthcare Stocks: Argenx Se (ARGX), Indivior (INDV)

Allison Bratzel

Piper Sandler

€911.76

Buy

31.19%

Upside

Reiterated

02/27/26

Argenx Se (ARGX) Gets a Buy from Piper Sandler

Jason Butler

Citizens JMP

€784.54→€800.65

Buy

15.20%

Upside

Reiterated

02/27/26

Argenx price target raised to $944 from $925 at CitizensArgenx price target raised to $944 from $925 at Citizens

Danielle Brill

Truist Financial

―

Buy

―

Reiterated

02/27/26

Analysts Are Bullish on Top Healthcare Stocks: Argenx Se (ARGX), Neurogene (NGNE)

Sean Laaman

Morgan Stanley

€983.85→€1,043.22

Buy

50.10%

Upside

Reiterated

02/27/26

Analysts Offer Insights on Healthcare Companies: Entrada Therapeutics Inc (NASDAQ: TRDA), Kymera Therapeutics (NASDAQ: KYMR) and Argenx Se (NASDAQ: ARGX)

Colleen M. Kusy

Robert W. Baird

€727.71→€735.35

Hold

5.81%

Upside

Reiterated

02/27/26

Argenx price target raised to $867 from $858 at BairdArgenx price target raised to $867 from $858 at Baird

Unknown Analyst

Jefferies

Not Ranked

Jefferies

€854.93

Buy

23.01%

Upside

Reiterated

02/27/26

Jefferies Remains a Buy on Argenx Se (ARGX)

Yatin Suneja

Guggenheim

€983.85→€949.93

Buy

36.68%

Upside

Reiterated

02/26/26

Argenx price target lowered to $1,120 from $1,160 at GuggenheimArgenx price target lowered to $1,120 from $1,160 at Guggenheim

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Argenx Se

3 Months

xxx

Success Rate

14/18 ratings generated profit

Average Return

+7.07%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 77.78% of your transactions generating a profit, with an average return of +7.07% per trade.

1 Year

Allison BratzelPiper Sandler

Success Rate

24/25 ratings generated profit

Average Return

+29.93%

reiterated a buy rating 2 months ago

Copying Allison Bratzel's trades and holding each position for 1 Year would result in 96.00% of your transactions generating a profit, with an average return of +29.93% per trade.

2 Years

xxx

Success Rate

34/34 ratings generated profit

Average Return

+64.85%

reiterated a xxx

rating 3 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +64.85% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1AEA Analyst Recommendation Trends

Rating

Dec 25

Jan 26

Feb 26

Mar 26

Apr 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 1AEA has received 45 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. 1AEA average Analyst price target in the past 3 months is 872.31.

Each month's total comprises the sum of three months' worth of ratings.

1AEA Financial Forecast

1AEA Earnings Forecast

Next quarter’s earnings estimate for 1AEA is €4.63 with a range of €2.18 to €6.34. The previous quarter’s EPS was €6.79. 1AEA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 1AEA has Performed in-line its overall industry.

1AEA Sales Forecast

Next quarter’s sales forecast for 1AEA is €1.12B with a range of €970.93M to €1.17B. The previous quarter’s sales results were €2.04B. 1AEA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 1AEA has Performed in-line its overall industry.

1AEA Stock Forecast FAQ

What is DE:1AEA’s average 12-month price target, according to analysts?

Based on analyst ratings, Argenx Se’s 12-month average price target is 872.31.

What is DE:1AEA’s upside potential, based on the analysts’ average price target?

Argenx Se has 25.51% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Argenx Se a Buy, Sell or Hold?

Argenx Se has a consensus rating of Strong Buy, which is based on 17 buy ratings, 2 hold ratings and 0 sell ratings.

What is Argenx Se’s share price target?

The average share price target for Argenx Se is 872.31. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €1,056.41 ,and the lowest forecast is €720.09. The average share price target represents 25.51% Increase from the current price of €695.

What do analysts say about Argenx Se?

Argenx Se’s analyst rating consensus is a Strong Buy. This is based on the ratings of 19 Wall Streets Analysts.

How can I buy shares of Argenx Se?

To buy shares of DE:1AEA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Argenx Se (1AEA) Stock Forecast & Price Target

1AEA Analyst Ratings

1AEA Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Argenx Se

1AEA Analyst Recommendation Trends

1AEA Financial Forecast

1AEA Earnings Forecast

1AEA Sales Forecast

1AEA Stock Forecast FAQ

Detailed List of Analyst Forecasts